Journey Medical Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

INTEREST EXPENSE (Tables)

INTEREST EXPENSE (Tables)

9 Months Ended

Sep. 30, 2022

INTEREST EXPENSE

Schedule of interest expense and financing fees


		Three-month periods ended						Nine-month periods ended
		September 30,						September 30,
		2022			2021			2022			2021
Interest payments on EWB term loan		$	333		$	—		$	710		$	—
Imputed Interest on acquired intangible assets			136			180			435			626
Amortization/Accretion			90			—			257			—
Fees on convertible preferred shares			—			378			—			648
Conversion premium ¹			—			365			—			628
Interest payable on convertible preferred shares			—			450			—			1,034
Total Interest Expense and Financing Fee		$	559		$	1,373		$	1,402		$	2,936

¹The conversion premium relates to the 15% discount at which the Class A Preferred Stock converted.